In their own responses to the senators’ inquiries last fall, both Pfizer and Lilly emphasized the independence of their ...

K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Donald Trump wants to 'take back' the US component of Ireland's pharma sector which supports 50,000 jobs, generates exports ...

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Tourmaline Bio (TRML – Research Report) today. The company’s shares ...

Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

DelveInsight recently conducted an in-depth MASH Market Size and Share Assessment to help a pharmaceutical client understand the evolving Metabolic Dysfunction-Associated Steatohepatitis (MASH) market ...

The Taoiseach Micheal Martin’s White House encounter with Donald Trump was controversial even before it was announced. Before any invitation had been extended, Sinn Fein said they were going ...

This article has been corrected to reflect that the senators asked UpScriptHealth to respond. In August 2024, Pfizer Inc ...